Quarterly report pursuant to Section 13 or 15(d)

License Agreements (Details)

v3.7.0.1
License Agreements (Details) - USD ($)
$ in Thousands
12 Months Ended
Sep. 22, 2016
Dec. 31, 2015
Dec. 31, 2013
Lilly | CERC-611      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Initial license acquisition payments $ 2,000    
Upfront payment due within 30 days $ 750    
Term within execution of license agreement 30 days    
Upfront payment due after first subject dosed $ 1,250    
Lilly | CERC-501      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Term within execution of license agreement   30 days  
Additional payments   $ 250  
Term of the study   9 months  
Lilly | CERC-501 | Research and development      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Initial license acquisition payments   $ 750  
Merck | CERC-301      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Total initial payments     $ 1,500
Additional payments     750
Merck | CERC-301 | Research and development      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Initial license acquisition payments     750
Merck | COMT      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Initial license acquisition payments     $ 200